Clinical trial
Secondary Fracture Prevention in Patients Hospitalized for Hip Fracture: Adding the Metabolic Treatment to the Surgical One.
NCT02223572 is registered in ClinicalTrials.gov with pninarotman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Secondary Fracture Prevention in Patients Hospitalized for Hip Fracture: Adding the Metabolic Treatment to the Surgical One.
- Lead sponsor
- pninarotman
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2014
- Completion date
- May 31, 2016
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.